Home › Onyx confirms, rejects Amgen's $120-per-share bid
 

Keywords :   


Onyx confirms, rejects Amgen's $120-per-share bid

2013-06-30 21:11:06| Biotech - Topix.net

Onyx Pharmaceuticals Inc. on Sunday confirmed that it received an unsolicited takeover bid from Amgen Inc. for $120 per share.

Tags: bid confirms rejects onyx

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11
15.11BELLE
15.11 Blu-ray 3
15.11LJN
15.11 vol.8
15.11 Kondo KRS-2552R2HV ICS
15.11 Lunatic Blood / Kleio
15.11111
More »